Dr. Fabrizio Michelassi, MD

Dr. Michelassi practices at Greenwich Hospital in Greenwich, Connecticut, part of Yale New Haven Health System.

Dr. Michelassi's NPI, 1952316499, was assigned on July 31, 2006. Dr. Michelassi graduated from University of Pisa Faculty of Medicine in 1975. Dr. Michelassi's New York license number on file is 140048.

Dr. Michelassi's primary practice is Greenwich Hospital, at 5 Perryridge Rd, Greenwich, CT 06830 in Fairfield County. The practice phone is (203) 863-3000.

Dr. Michelassi's primary practice is Greenwich Hospital in Greenwich, Connecticut, part of Yale New Haven Health System. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Michelassi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Michelassi practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Michelassi's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Michelassi is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Michelassi's licenses on file in 4 states: New York, Florida, New Jersey and Illinois.

Dmand AI lists colon removal and intestinal or bowel obstruction among the conditions Dr. Michelassi treats.

CMS data shows 12 Medicare services from Dr. Michelassi across 1 procedure code in 2022, all of them office visits, for 17 Medicare patients. Medicare paid $2,471 for them. Every service was in an office.

CMS counts 17 Medicare patients who saw Dr. Michelassi in 2024. 75% of them have high cholesterol. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Michelassi's median patient age at 54, with 29% women.

In 2024, Dr. Michelassi wrote 15 Medicare Part D claims. 100% of them were for generic drugs. They cover 1 drug, with $1,392 in total drug cost. In 2022, CMS named 20 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Michelassi for performance year 2024, reported through an alternative payment model (APM). Dr. Michelassi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 134 papers to Dr. Michelassi, published from 2007 to 2024. 2016 was the busiest year, with 4. The most frequent topics are Adenocarcinoma, Postoperative Complications and Crohn Disease. Dr. Michelassi has published most often in Ann Surg. Dr. Michelassi's most frequent co-authors are Heather Lynn Yeo, MD, Alessandro Fichera, MD and Richard B. Arenas, MD.

Dmand AI links Dr. Michelassi to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Crohn Disease and Inflammatory Bowel Diseases.

Dmand AI lists 39 awards for Dr. Michelassi, most recently America's Top Doctors in 2014.

Dr. Michelassi graduated from University of Pisa Faculty of Medicine in 1975. Dr. Michelassi is a member of Academy of Surgical Research, American Board of Surgery, ACS, American Gastroenterologic Association, American Pancreatic Association and American Society of Clinical Oncology.

Dr. Michelassi is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.